Harbour BioMed appoints Sana Biotechnology CSO Dhavalkumar Patel as scientific advisor
PUBT · 19h ago
Share
Listen to the news
- HBM Holdings said Harbour BioMed appointed Dhavalkumar Patel as a scientific advisor on June 11, 2026.
- Patel is executive vice president, chief scientific officer at Sana Biotechnology.
- He previously served as executive vice president, chief scientific officer at UCB.
- Earlier roles include head of research for NIBR Europe at Novartis, following academic leadership posts at UNC Chapel Hill, Duke University.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606112119PR_NEWS_USPR_____CN82280) on June 12, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved